46 related articles for article (PubMed ID: 36987423)
1. Expression and clinical significance of CA125, CA153 and CEA in nipple discharge of breast cancer patients.
Geng J; Jinli S; Guo W; Li H; Dan Y; Gao Y
J Med Biochem; 2024 Apr; 43(2):234-242. PubMed ID: 38699697
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum synaptophysin-like 1 protein levels in breast cancer.
Kosem YOT; Uzun H; Velidedeoglu M; Kocael P; Dumur S; Simsek O
J Med Biochem; 2024 Apr; 43(2):273-280. PubMed ID: 38699696
[TBL] [Abstract][Full Text] [Related]
3. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives.
Infante M; Fabi A; Cognetti F; Gorini S; Caprio M; Fabbri A
J Exp Clin Cancer Res; 2019 Jan; 38(1):12. PubMed ID: 30621730
[TBL] [Abstract][Full Text] [Related]
4. Can we prevent BRCA1-associated breast cancer by RANKL inhibition?
Kotsopoulos J; Singer C; Narod SA
Breast Cancer Res Treat; 2017 Jan; 161(1):11-16. PubMed ID: 27783278
[TBL] [Abstract][Full Text] [Related]
5. Serum fetuin-A and RANKL levels in patients with early stage breast cancer.
Afsar CU; Aral H; Can O; Can TD; Karacetin D; Ali NM; Umar GR; Karabulut S
J Med Biochem; 2023 Mar; 42(2):249-257. PubMed ID: 36987423
[TBL] [Abstract][Full Text] [Related]
6. [Changes in serum osteoprotegerin/receptor activator of nuclear factor-κB ligand and related indexes of calcium and phosphorus in the early stage of severe burn patients].
Gong X; Ye ZQ; Zhang W; Yu G; Ruan QF; Xie WG
Zhonghua Shao Shang Za Zhi; 2020 Aug; 36(8):704-709. PubMed ID: 32829609
[No Abstract] [Full Text] [Related]
7. Osteoprotegerin, RANKL, ADMA, and Fetuin-A serum levels in children with type I diabetes mellitus.
Chrysis D; Efthymiadou A; Mermigka A; Kritikou D; Spiliotis BE
Pediatr Diabetes; 2017 Jun; 18(4):277-282. PubMed ID: 27028343
[TBL] [Abstract][Full Text] [Related]
8. Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy.
Todenhöfer T; Hennenlotter J; Leidenberger P; Wald A; Hohneder A; Kühs U; Mischinger J; Aufderklamm S; Gakis G; Blumenstock G; Stenzl A; Schwentner C
BJU Int; 2014 Jan; 113(1):152-9. PubMed ID: 23360112
[TBL] [Abstract][Full Text] [Related]
9. RANKLed by the Complexity of Signaling in Breast Cancer Metastasis to the Brain.
Wang K; Hackney JR; Siegal GP; Wei S
Clin Breast Cancer; 2020 Oct; 20(5):e569-e575. PubMed ID: 32381383
[TBL] [Abstract][Full Text] [Related]
10. Possible Prognostic Potential of RANKL and OPG in Metastatic Breast Cancer Egyptian Females.
Shaker OG; Elbaz EM
Asian Pac J Cancer Prev; 2020 Feb; 21(2):355-361. PubMed ID: 32102511
[TBL] [Abstract][Full Text] [Related]
11. Alpha-2 Heremans Schmid Glycoprotein (AHSG) promotes the proliferation of bladder cancer cells by regulating the TGF-β signalling pathway.
Dong Y; Ding D; Gu J; Chen M; Li S
Bioengineered; 2022 Jun; 13(6):14282-14298. PubMed ID: 35746836
[TBL] [Abstract][Full Text] [Related]
12. Fetuin-A Promotes 3-Dimensional Growth in LNCaP Prostate Cancer Cells by Sequestering Extracellular Vesicles to Their Surfaces to Act as Signaling Platforms.
Ochieng J; Korolkova OY; Li G; Jin R; Chen Z; Matusik RJ; Adunyah S; Sakwe AM; Ogunkua O
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409390
[TBL] [Abstract][Full Text] [Related]
13. Probiotics-rich emulsion improves insulin signalling in Palmitate/Oleate-challenged human hepatocarcinoma cells through the modulation of Fetuin-A/TLR4-JNK-NF-κB pathway.
Mularczyk M; Bourebaba Y; Kowalczuk A; Marycz K; Bourebaba L
Biomed Pharmacother; 2021 Jul; 139():111560. PubMed ID: 33839491
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum Nestin and HOTAIR rs12826786 C>T polymorphism as screening tools for breast cancer in Egyptian women.
Aglan SA; Elsammak M; Elsammak O; El-Bakoury EA; Elsheredy HG; Ahmed YS; Sultan MH; Awad AM
J Med Biochem; 2021 Jan; 40(1):17-25. PubMed ID: 33584136
[TBL] [Abstract][Full Text] [Related]
15. RANKL biology: bone metabolism, the immune system, and beyond.
Ono T; Hayashi M; Sasaki F; Nakashima T
Inflamm Regen; 2020; 40():2. PubMed ID: 32047573
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
